KV Asia Capital sees strong growth potential for the education sector in Southeast Asia. The firm’s latest investment in Malaysia-based APIIT Education Group reflects confidence in this vision
Crescent Capital Partners has acquired Australia-based clinical research organization (CRO) Nucleus Network from The Baker Institute, an independent research institute that focuses on heart disease and diabetes.
Despite their strong growth potential, Australian food crops have attracted little activity from the private equity community. Investors’ interest is restrained by the high hurdles to managing these assets
Quadrant Private Equity has acquired Darrell Lea, a candy maker based in Australia and New Zealand.
Bianlifeng, a Chinese PE-backed cashier-free convenience store operator, has acquired a controlling stake in its peer Lingwa. Financial terms were not disclosed.
CITIC Capital has increased its stake in Harbin Pharmaceutical Group to 60.86%, becoming the controlling shareholder of the Chinese state-backed business in which it has been an investor since 2005.
Buyout firms are responding to higher valuations by doing more to ensure they can bring about transformation in portfolio companies. They are also being more careful in terms of sector selection and leverage
India has broadened its regulations on foreign direct investment (FDI), permitting unconditional 100% FDI in sectors including single-brand retail trading (SBRT).
Korea's VIG Partners completes its second OEM deal in six months with the $207 million acquisition of Youyoung, a supplier of materials used in running shoes
CITIC Capital has completed the acquisition of Axilone, a Europe-headquartered packaging supplier to the cosmetics industry. The deal facilitates an exit for Oaktree Capital Management.
Emerald Media, a pan-Asian media and entertainment platform backed by KKR, has acquired a majority stake in Cosmos-Maya, an animation studio based in Singapore and India.
Australian container supplier Brambles has agreed to sell its North American recycled pallet business to Grey Mountain Partners, a US-based mid-market GP, for an enterprise value of $115 million.
Chinese companies return in strength to US bourses as investors leverage public market highs; Australia a bright spot as Asia fundraising slows; 2017 sets new record for PE investment on back of big buyouts, tech deals
Technology is directly or indirectly redefining business models across Asia. Private equity investors must embrace change or risk seeing returns damaged as portfolio companies are disrupted
J-Star has acquired a majority stake in Japanese restaurant operator Section Eight and invested in new and pre-owned car dealer Sanwa Service.
Hony Capital has partnered with its portfolio company China Glass Holdings (CGH) to launch a $300 million fund that will invest in glass production projects in countries covered by the One Belt One Road (OBOR) initiative.
KV Asia Capital has supported a management buyout of APIIT Education Group, the holding company for several primary, secondary and tertiary education assets in Malaysia, from Ekuinas for an enterprise valuation of MYR725 million ($180 million).
Brookfield Asset Management has agreed to buy the Westinghouse nuclear power unit from Japan’s Toshiba Corporation in a deal worth approximately $4.6 billion.
Australian surfwear brand Billabong International has agreed to an acquisition by industry peer Boardriders, which owns the Quiksilver brand. Both companies are backed by Oaktree Capital Management.
VIG Partners has acquired Youyoung, a Korea-based supplier of materials used in running shoes, for an enterprise valuation of KRW220 billion ($207 million).
State-backed private equity investor China Integrated Circuit Industry Investment Fund (IC Fund) has agreed to buy an approximately 19% stake in domestic computer chip maker Hua Hong Semiconductor for $400 million.
Yichen Zhang, CEO of CITIC Capital, discusses fundraising, working on outbound deals, the appeal of China divestments by foreign companies, and leading a multi-strategy firm
Allegro Funds secured a 25x return on Great Southern Rail by helping the formerly no-frills Australian transport company find a new life as a stylized high-end tourism attraction
J-Star has agreed to exit Japanese drugstore chain Aisei Pharmacy to company management less than two years after completing a JPY11.4 billion ($101 million) privatization.